Frontline Treatment for Follicular Lymphoma

A review of the GALLIUM trial and the use of obinutuzumab versus rituximab in the frontline setting of follicular lymphoma. Website: https://www.onclive.com Twitter:   / onclive   Facebook:   / onclive   LinkedIn:   / onclive